Lomalizumab: un nouvel anti-IgE pour le traitement de lasthme sévère | Zendy

AI Assistant Blog Pricing

Open Access

Lomalizumab: un nouvel anti-IgE pour le traitement de lasthme sévère

Author(s) -

Philip Taramarcaz,

Conrad Hauser

Publication year - 2008

Publication title -

forum médical suisse

Language(s) - French

Resource type - Journals

eISSN - 1661-6146

pISSN - 1661-6138

DOI - 10.4414/fms.2008.06432

Subject(s) - omalizumab , medicine , immunoglobulin e , antibody , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.